Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Zesteem for healing of split thickness skin graft donor sites
2006-005049-12Phase 3Completed
- Sponsor
- Renovo
- Start
- Nov 2006
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in Not applicable comparing Zesteem intradermal arm with Placebo intradermal arm (2 arms). Primary endpoint: Time to complete wound closure at the skin graft donor site. Started Nov 2006; status: completed.
02
Drugs
Zesteem
03
Conditions
Not applicable
Beyond the preview
Go deeper on 2006-005049-12.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2006-005049-12.